1. J Exp Med. 2021 Feb 1;218(2):e20201884. doi: 10.1084/jem.20201884.

A knockout combination for MPN stem cells.

Bywater M(1)(2), Lane SW(1)(2)(3).

Author information:
(1)Cancer Program, QIMR Berghofer Medical Research Institute, Herston, 
Australia.
(2)University of Queensland, Brisbane, Australia.
(3)Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, 
Australia.

Comment on
    J Exp Med. 2021 Feb 1;218(2):e20201268. doi: 10.1084/jem.20201268.

Myeloproliferative neoplasms (MPNs) are a group of blood cancers that are 
maintained by stem cell populations. In this issue of JEM, Dagher et al. 
(https://doi.org/10.1084/jem.20201268) combine arsenic and interferon α to 
deliver a knockout punch to MPN stem cells and provide new hope to cure patients 
with MPNs.

© 2020 Bywater and Lane.

DOI: 10.1084/jem.20201884
PMCID: PMC7671566
PMID: 33185683 [Indexed for MEDLINE]